STOCK TITAN

Protext Mobility, Inc. (OTC: TXTM) Announces CEO Statement Following Removal of Caveat Emptor Designation

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

Protext Mobility (OTC: TXTM) released a CEO statement dated October 31, 2025 after the removal of its Caveat Emptor designation. The CEO says management and board are aligned on growth, citing the company's shift to transparency and accountability.

Key disclosures: the company reports its President and Chairman purchased more than 200 million shares on the open market since 2024; the CEO holds preferred shares and does not intend to convert them to common stock; management stated there is no plan for a reverse stock split. The CEO said he plans additional share purchases and may donate shares back to the company to support business development.

Loading...
Loading translation...

Positive

  • Removal of Caveat Emptor designation (company re-enters normal disclosure status)
  • President and Chairman purchased more than 200 million shares since 2024
  • CEO holds preferred shares and does not intend to convert (no dilution risk)
  • Management publicly stated no plan for a reverse stock split

Negative

  • Insider purchases concentrated in one executive/board member could limit liquidity
  • Planned CEO share donations may create timing uncertainty for capital structure

News Market Reaction 1 Alert

% News Effect

On the day this news was published, TXTM declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Protext Mobility, Inc. (OTC: TXTM) (“TXTM”), an emerging biotechnology company pioneering advancements in plant-based therapeutics, today released an official statement from Chief Executive Officer Mr. Dylon Du Plooy, addressing shareholders in light of the company’s continued operational and strategic progress following the removal of the Caveat Emptor designation.

Message to Shareholders:

Following the removal of the Caveat Emptor designation, Protext Mobility Inc. (OTC: TXTM) has entered a new phase of growth — one built on transparency, accountability, and leadership alignment.

As Chief Executive Officer, I firmly believe in TXTM’s long-term potential. To demonstrate that conviction, Our President and Chairman of the Board purchased more than 200 million shares of TXTM common stock on the open market since 2024. These purchases represent long-term holdings and serve as a clear signal that management and shareholders are fully aligned in our shared vision for sustained growth.

Additionally, I hold preferred shares that I have no intention to convert into common stock. This ensures there is no dilution risk from management. In fact, my plan is to acquire additional shares and donate a portion back to the company to further support business development and strategic initiatives.

Importantly, the company is not planning, considering, or preparing for any reverse stock split. Management’s commitment remains focused on strengthening fundamentals, driving organic growth, and protecting shareholder value without resorting to measures that could adversely impact the capital structure.

My goal as Chief Executive Officer is straightforward: to strengthen the company, protect shareholder value, and build continued momentum as we enter this exciting new chapter.

Thank you for your confidence and support.

Sincerely,
Mr. Dylon Du Plooy
Chief Executive Officer
Protext Mobility, Inc. (OTC: TXTM)

About Protext Mobility, Inc. (OTC: TXTM)

Protext Mobility, Inc. is a biotechnology company pioneering the development of plant-based therapeutics through proprietary live plant extraction technologies. The company’s mission is to deliver highly bioavailable botanical formulations for nutraceutical and pharmaceutical applications — driving innovation in global wellness through nature and science.

Investor & Media Contact

Dylon Du Plooy - Investor Relations
dylon@rsammd.co.za

Dr. J - Corporate Communications
exportintl@aol.com

Follow Protext Mobility on X: https://x.com/ProtextP

Safe Harbor Statement

This release contains forward-looking statements reflecting Protext Mobility, Inc.’s current views and expectations regarding future events and performance. Such statements are subject to risks and uncertainties that could cause actual results to differ materially. The company assumes no obligation to update forward-looking statements except as required by law.


FAQ

What did Protext Mobility (OTC: TXTM) announce on October 31, 2025?

The CEO issued a shareholder statement after removal of the Caveat Emptor designation and disclosed insider share purchases and capital intentions.

How many shares did Protext Mobility's President and Chairman buy for TXTM?

The company said the President and Chairman purchased more than 200 million shares of TXTM common stock on the open market since 2024.

Will Protext Mobility (OTC: TXTM) do a reverse stock split?

Management stated the company is not planning, considering, or preparing for any reverse stock split.

Does the CEO plan to convert preferred shares into TXTM common stock?

The CEO said he holds preferred shares and has no intention to convert them, aiming to avoid dilution.

Will Protext Mobility's CEO buy more TXTM shares or support the company financially?

The CEO said he plans to acquire additional shares and may donate a portion back to the company to support business development.
Protext Mobility Inc

OTC:TXTM

TXTM Rankings

TXTM Latest News

TXTM Stock Data

27.25M
Biotechnology
Healthcare
Link
United States
Fort Lauderdale